NOVEL THERAPIES FOR CANCER

The invention relates to 6-{4-[1 -(Propan-2-yl)piperidin-4-yl]-1,4-diazepan-1 -yl}-N- (pyridin-4-yl)pyridine-2-carboxamide, or a pharmaceutically acceptable salt thereof, for use in treatment of CNS cancers. The invention also relates to combination treatments with irradiation and/or a chemotherapeu...

Full description

Saved in:
Bibliographic Details
Main Authors RICHARDSON, PETER, WALLING, JACQUELINE MARY, FESTUCCIA, CLAUDIO
Format Patent
LanguageEnglish
French
Published 06.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to 6-{4-[1 -(Propan-2-yl)piperidin-4-yl]-1,4-diazepan-1 -yl}-N- (pyridin-4-yl)pyridine-2-carboxamide, or a pharmaceutically acceptable salt thereof, for use in treatment of CNS cancers. The invention also relates to combination treatments with irradiation and/or a chemotherapeutic agent for use in the treatment of cancer L'invention concerne 6-{4-[1-(propane-2-yl)pipéridine-4-yl]-1,4-diazépan-1 -yl}-N-(pyridine-4-yl)pyridine-2-carboxamide, ou un sel pharmaceutiquement acceptable de celui-ci, pour une utilisation dans le traitement de cancers du système nerveux central. L'invention concerne également des polythérapies faisant intervenir les rayons et/ou un agent de chimiothérapie pour une utilisation dans le traitement du cancer.
Bibliography:Application Number: CA20162979167